Tīmeklis2024. gada 13. febr. · 目前,EZH2抑制剂大多处于临床开发的前期,很多临床试验在摸索中前进,除了Tazemetostat,多数EZH2抑制剂上市大概至少需要3年的时间,尤其 … TīmeklisGSK-126 is recognized as an inhibitor of enhancer of zeste homolog-2 (EZH2) activity. Because of its inhibition of EZH2 activation, GSK-126 is considered a potential anti …
MS1943 CAS:2225938-17-8 Probechem Biochemicals
Tīmeklis2024. gada 8. marts · GSK126 是一种有效,选择性的 EZH2 甲基转移酶抑制剂,IC50 为 9.9 nM。. MCE 的所有产品仅用作科学研究,我们不为任何个人用途提供产品和服务. 生产商:MedChemExpress(MCE) 分子式: C31H38N6O2 分子量:526.67 CAS No. : 1346574-57-9 体外:gsk126 可以有效地抑制野生类型和突变的 ezh2 甲基转移酶活 … Tīmeklis生物活性. GSK126 (GSK2816126A, GSK2816126) 是一种有效的,高选择性 EZH2 methyltransferase 抑制剂, IC50 为9.9 nM,对 EZH2 的选择性比其他20种人甲基转移酶高1000多倍。. 在体外,EZH2野生型和突变型DLBCL细胞系中,GSK126最有效地抑制H3K27me3,其次是H3K27me2。. GSK126也能有效抑制 ... dermatology and laser associates medford
EZH2 as a Regulator of CD8+ T Cell Fate and Function
Tīmeklis2024. gada 6. okt. · Enhancer of zeste 2 (EZH2) is the catalytic subunit of the Polycomb Repressive Complex 2 (PRC2) that mediates di- and trimethylation of histone 3 lysine 27 effectively precluding successful gene transcription at these loci. This class of epigenetic modifications facilitates the maintenance of tissue-specific cellular transcriptional … TīmeklisSevoflurane post-conditioning alleviates neonatal rat hypoxic-ischemic cerebral injury via Ezh2-regulated autophagy Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled. Tīmeklis2024. gada 11. janv. · GSK126 是一种有效,选择性的 EZH2 甲基转移酶抑制剂,IC50 为 9.9 nM。. GSK126有效地抑制野生型和突变型EZH2甲基转移酶活性,具有相似的效力(Ki = 0.5-3nM),与使用的底物无关,并且与S-腺苷甲硫氨酸(SAM)竞争并且与肽底物不竞争。. GSK126对其他甲基转移酶和多种 ... dermatology and cosmetic journal